• Clinical Professor of Medicine, UBC
• Program Director, VGH Interventional Cardiology Fellowship Training Program
• Associate Editor, JACC Cardiovascular Intervention
• Primary research interests include Spontaneous Coronary Artery Dissection (SCAD), Left Atrial Appendage Closure, and antithrombotic therapy
• ~200 publications, >90 abstracts, >500 presentations/chair/moderator/panelist
• PI or Co-PI: Canadian SCAD Study, CanSCAD Genetics Study, CanSCAD3000 Study, ASAP-TOO Study, Canadian Watchman Study, Canadian ACP/Amulet Registry, SAFER-SCAD Study, PRYME Study, TAP-CABG, ELAPSE

Dr. Jacqueline Saw is an Interventional Cardiologist at Vancouver General Hospital (VGH) with a joint appointment at St Paul’s Hospital. She is a Clinical Associate Professor of Medicine at the University of British Columbia, and Program Director of the Interventional Cardiology Fellowship Program at VGH. She also served as the Head of VGH Cardiology Clinical Trials Research. She is an active clinician, researcher and educator.

She was awarded Canada Scholar and the Dean’s Entrance Scholarship for Natural Sciences at Simon Fraser University for her undergraduate degree. She obtained her medical doctorate at the University of Ottawa, graduating summa cum laude. She completed her Internal Medicine and Cardiology residencies at the University of British Columbia, and served as chief cardiology fellow. She then completed her Interventional Cardiology fellowship training at Cleveland Clinic Foundation, which encompassed carotid, peripheral and structural training. She has been an active staff with the Division of Cardiology at VGH and St Paul’s Hospital since 2004. She is also a physician proctor for left atrial appendage (LAA) closure with the Amplatzer Cardiac Plug/Amulet and WATCHMAN devices globally.

Dr. Saw is a pioneer and leader in research and management of spontaneous coronary artery dissection (SCAD) (http://scad.ubc.ca), and is the principal investigator of the Canadian Institutes of Health Research (CIHR) funded multi-center prospective Canadian SCAD Study. Her other research interests include LAA closure, non-atherosclerotic coronary artery disease (including coronary fibromuscular dysplasia), antiplatelet therapy, percutaneous coronary intervention, carotid artery stenting, peripheral arterial disease and intervention. She is also the principal investigator of PRYME, NACAD, SAFER-SCAD, Canadian WATCHMAN Registry, TAP-CABG, and ELAPSE studies. She has authored over 100 peer-reviewed publications, including scientific research studies, review articles and book chapters. She is also the editor of three textbooks on carotid artery stenting and LAA closure.